BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.
BioAffinity Technologies has raised $3.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
BioAffinity Technologies is headquartered in San Antonio, United States.
BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.
BioAffinity Technologies is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioAffinity Technologies — Funding & Investors." VCBacked, June 17, 2026, https://www.vcbacked.co/company/bioaffinity-technologies. Accessed August 14, 2026.
VCBacked. (2026). BioAffinity Technologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/bioaffinity-technologies
{{cite web |title=BioAffinity Technologies — Funding & Investors |url=https://www.vcbacked.co/company/bioaffinity-technologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated